Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Livzon Pharmaceutical Group has ...

Livzon Pharmaceutical Group Inc. is set to hold its 2024 second class meeting of H Shareholders on December 24, where a special resolution on the repurchase of A Shares will be considered. The A Share ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Livzon Pharmaceutical Group ( (HK:1513)) ...

Livzon Pharmaceutical Group ( (HK:1513)) just unveiled an update. Livzon Pharmaceutical Group Inc. has announced its 2025 first extraordinary general meeting scheduled for December 10, 2025. The ...

The positions in the table below reflect the Livzon Pharmaceutical Group's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links ...

SHANGHAI, June 14 (Reuters) - A second Chinese drugmaker has applied for approval to sell a generic version of Novo Nordisk's (NOVOb.CO), opens new tab blockbuster diabetes drug Ozempic in China.

* PROPOSES TO ENTER AGREEMENT PURSUANT TO WHICH JOINCARE TO SELL 49% EQUITY INTERESTS IN LIVZON MAB FOR RMB294 MILLION Source text for Eikon: Further company coverage: Sign up here. Future of ...

Livzon Pharmaceutical Group (HK:1513) has released an update. Pick the best stocks and maximize your portfolio: Livzon Pharmaceutical Group has entered into a Patent and Technology Transfer Agreement ...

SHANGHAI (Reuters) - A second Chinese drugmaker has applied for approval to sell a generic version of Novo Nordisk's blockbuster diabetes drug Ozempic in China. Livzon Pharmaceutical Group said this ...